|
Status |
Public on Aug 01, 2023 |
Title |
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
Web link |
https://www.cell.com/immunity/fulltext/S1074-7613(24)00413-8
|
|
|
Citation(s) |
39276771 |
|
Submission date |
Apr 17, 2023 |
Last update date |
Sep 17, 2024 |
Contact name |
David Barras |
E-mail(s) |
[email protected]
|
Organization name |
Centre hospitalier universitaire vaudois
|
Department |
Oncology
|
Street address |
AGORA, Bugnon 25A
|
City |
Lausanne |
State/province |
Vaud |
ZIP/Postal code |
1005 |
Country |
Switzerland |
|
|
Platforms (4)
|
GPL15520 |
Illumina MiSeq (Homo sapiens) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
GPL22790 |
Illumina MiniSeq (Homo sapiens) |
|
Samples (89)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE229858 |
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma [scRNA-seq] |
GSE229860 |
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma [scTCR-seq] |
GSE234352 |
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma [TCR-Seq] |
|
Relations |
BioProject |
PRJNA956469 |